Entourage Health Financials
| ETRGF Stock | USD 0.01 0 25.00% |
Entourage |
Understanding current and past Entourage Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Entourage Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Entourage Health's assets may result in an increase in income on the income statement.
Entourage Health Stock Summary
Entourage Health competes with Genomma Lab. Entourage Health Corp. engages in the production and distribution of cannabis products for medical and adult-use markets in Canada. The company was formerly known as WeedMD Inc. and changed its name to Entourage Health Corp. in July 2021. Entourage Health is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| ISIN | CA2938611001 |
| Business Address | 276 Queen Street |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | entouragehealthcorp.com |
| Currency | USD - US Dollar |
Entourage Health Key Financial Ratios
There are many critical financial ratios that Entourage Health's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Entourage Health Corp reports annually and quarterly.Entourage Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Entourage Health's current stock value. Our valuation model uses many indicators to compare Entourage Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Entourage Health competition to find correlations between indicators driving Entourage Health's intrinsic value. More Info.Entourage Health Corp is rated # 4 in return on equity category among its peers. It also is rated # 4 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Entourage Health's earnings, one of the primary drivers of an investment's value.Entourage Health Corp Systematic Risk
Entourage Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Entourage Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Entourage Health Corp correlated with the market. If Beta is less than 0 Entourage Health generally moves in the opposite direction as compared to the market. If Entourage Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Entourage Health Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Entourage Health is generally in the same direction as the market. If Beta > 1 Entourage Health moves generally in the same direction as, but more than the movement of the benchmark.
Entourage Health December 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Entourage Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Entourage Health Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of Entourage Health Corp based on widely used predictive technical indicators. In general, we focus on analyzing Entourage Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Entourage Health's daily price indicators and compare them against related drivers.
| Downside Deviation | 14.84 | |||
| Information Ratio | 0.0352 | |||
| Maximum Drawdown | 112.65 | |||
| Value At Risk | (25.93) | |||
| Potential Upside | 36.67 |
Complementary Tools for Entourage Pink Sheet analysis
When running Entourage Health's price analysis, check to measure Entourage Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entourage Health is operating at the current time. Most of Entourage Health's value examination focuses on studying past and present price action to predict the probability of Entourage Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entourage Health's price. Additionally, you may evaluate how the addition of Entourage Health to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |